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Abstract 24 
The aim of this study was to investigate if a pre-exercise alkalosis mediated attenuation of HSP72 had 25 
any effect on the response of the same stress protein after a subsequent exercise. Seven physically 26 
active males (25.0 ± 6.5 years, 182.1 ± 6.0 cm, 74.0 ± 8.3 kg, peak aerobic power (PPO) 316 ± 46 W) 27 
performed a repeated sprint exercise (EXB1) following a dose of 0.3 g kg-1 body mass of sodium 28 
bicarbonate (BICARB), or a placebo of 0.045 g kg-1 body mass of sodium chloride (PLAC). 29 
Participants then completed a 90-min intermittent cycling protocol (EXB2). Monocyte expressed 30 
HSP72 was significantly attenuated after EXB1 in BICARB compared to PLAC, however there was no 31 
difference in the HSP72 response to the subsequent EXB2 between conditions. Furthermore there was 32 
no difference between conditions for measures of oxidative stress (protein carbonyl and HSP32). These 33 
findings confirm the sensitivity of the HSP72 response to exercise induced changes in acid-base status 34 
in vivo, but suggest that the attenuated response has little effect upon subsequent stress in the same 35 
day. 36 
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Introduction 53 
Exposure to an extracellular acidosis has been demonstrated to increase HSP72 gene activity in 54 
monkey kidney cells (pH = 6.8) (Gapen and Moseley, 1995) and the expression of HSP72 protein in 55 
cultured rat astrocytes (pH = 5.2) (Narasimhan et al., 1996), with a potential mechanism being the 56 
initiation of protein degradation via the ATP dependent ubiquitin proteasome pathway (Mitch et al. 57 
1994, Price et al. 1994). However, these in vitro models are difficult to apply to the whole organism 58 
due to the extreme pH limits employed. Recent research in human studies inducing a pre-exercise 59 
alkalosis using sodium bicarbonate (NaHCO3) has demonstrated an attenuation of the stress protein 60 
following high-intensity anaerobic exercise (Peart et al. 2011, 2013a), but not following a longer sub-61 
maximal 90-min cycling effort (Peart et al. 2013b). These findings therefore suggest that HSP72 is also 62 
sensitive to less extreme shifts in acid-base balance in vivo (pH = 7.15). However it was not 63 
investigated in this previous work whether the attenuated response of HSP72 would have any 64 
implications for the stress response from a subsequent exercise.  65 
 66 
One of the primary purposes of HSP72 is to facilitate cross-tolerance to a subsequent stressor, and 67 
Madden et al. (2008) proposed that its expression could enhance cellular tolerance to the stress of 68 
exercise. Moreover authors have shown that increases in monocyte expressed HSP72 in particular can 69 
provide protection to oxidative stress in a subsequent exercise (Taylor et al, 2012). In light of this it is 70 
possible that attenuating the acute exercise induced HSP72 response to exercise via NaHCO3 may 71 
inhibit this particular mechanism of defence to a second bout of exercise.  72 
 73 
The aim of this study was to confirm previously published data and further expand whether this would 74 
have any implications for the subsequent HSP72 response and oxidative stress response to a second 75 
exercise in the same day. 76 
  77 
Materials and Methods 78 
Participants 79 
Seven recreationally active non-smoking males (mean ± SD; age 25.0 ± 6.5 years, height 182.1 ± 6.0 80 
cm, body mass 74.0 ± 8.3 kg, absolute peak power output (PPO) 316 ± 46 W and relative PPO 4.3 ± 81 
1.0 W.kg-1) volunteered for the study. All participants provided written informed consent in accordance 82 
with the departmental and University ethical procedures and following the principles outlined in the 83 
Declaration of Helsinki. None of the participants were supplementing their diet with any ergogenic aids 84 
prior to testing. Participants were instructed not to exercise in the 24-h prior to testing, and to also 85 
abstain from foods and beverages high in alcohol, fat and caffeine (Sandstrom et al., 2009, Taylor et 86 
al., 2010a) 87 
  88 
Exercise protocols 89 
Prior to the experimental trials all participants performed a ramped PPO test on a cycle ergometer 90 
(Lode Sport Excalibur, Netherlands). The test started with a 5-min warm up at 50 W, and workload 91 
increased thereafter by 30 W.min-1 until volitional exhaustion. The PPO from this test was used to 92 
prescribe an individual workload for both exercise bouts (EXB1 and EXB2 respectively). EXB1 was a 93 
high-intensity anaerobic exercise consisting of 10 x 15-s sprints against 120% PPO separated by 45-s 94 
active recovery and EXB2 was a 90-min interval cycling exercise (10 x 9-min blocks of exercise 95 
consisting of 306 s at 40 % PPO, 204 s at 60 % PPO, 8 s at 0 W, 14 s sprint at 120 % PPO and 8 s at 0 96 
W). Both protocols have been described in full in Peart et al (2013a) and Peart et al (2013b) 97 
respectively. 98 
  99 
 Experimental Design 100 
Participants reported to the laboratory on three occasions, with the first visit consisting of the described 101 
PPO test followed by a familiarisation to the testing procedures. Visits two and three were the 102 
experimental trials completed in a blinded and randomised manner. These trials began with ingestion 103 
of either 0.3 g.kg.BW-1 NaHCO3 (BICARB) or an equimolar (sodium) dose of sodium chloride (NaCl - 104 
0.045g.kg.BW-1) placebo (PLAC), followed by a 60-min rest period. The NaHCO3 and NaCl were 105 
ingested in gelatine capsules as opposed to in a liquid solution as per previous research (Artioli et al 106 
2007, Flinn et al 2014, Peart et al 2013b) as the capsules may facilitate participant blinding by 107 
removing the taste (Peart et al, 2012) and offer a more preferable mode of consumption (Carr et al, 108 
2011). All of the gelatine capsules were opaque so participants could unknowingly ingest empty 109 
capsules to allow a matched number of capsules per condition. 110 
    111 
A venous blood sample was taken 60-min post-ingestion, after which participants performed EXB1. 112 
After 90-min rest (determined from the peak HSP72 response observed in Peart et al., (2013b)) 113 
participants began EXB2. A venous blood sample was taken immediately post EXB2, and a final 114 
venous blood sample was taken 60-min post EXB2. Fig 1 provides a visual representation of the 115 
experimental trials. Capillary blood samples for the measurement of acid-base variables (pH, HCO3-, 116 
base excess and lactate) were taken immediately before and 60-min after ingestion of the pills (both 117 
pre-exercise), immediately post EXB1 and prior to EXB2. All capillary blood samples were collected 118 
in 100 µl balanced heparin blood gas capillary tubes and analysed immediately (Radiometer, ABL800, 119 
Copenhagen, Denmark). Venous blood samples for the measurement of HSP72 were drawn from the 120 
antecubital vein into potassium EDTA Vacuette tubes (Vacuette®, Greiner BIO-one, UK) at the time 121 
points already described.  122 
 123 
Oxidative stress was quantified by the measurement of protein carbonyl using a commercially available 124 
assay kit (Cayman, UK). The expression of HSP72 and HSP32 were measured via flow cytometry in 125 
monocytes using a well-established assay method (Sandstrom et al. 2009, Vince et al., 2010 Peart et al 126 
2013b, Taylor et al, 2012). Whole blood (100 µl) was transferred from the potassium EDTA tubes into 127 
2 ml of red blood cell lysis buffer (diluted 1/10 with distilled water; Erythrolyse, AbD Serotec, UK) 128 
and left to incubate for 10 minutes. Following incubation, samples were centrifuged for 5-min at 3000 129 
rpm to pellet the white blood cells, and the resultant supernatant discarded. White blood cells were 130 
subsequently washed in 2 ml phosphate buffering solution (PBS) and centrifuged for 5-min at 3000 131 
rpm, with the supernatant discarded. Following a second wash 100µl of Fix solution (Leucoperm 132 
Reagent A, AbD Serotec) was added to the samples and left to incubate for 15-min. After incubation, 133 
samples were washed as above and permeabilised by the addition of 100 µl of Perm solution 134 
(Leucoperm Reagent B, AbD Serotec). Each sample was then divided into two 50 µl aliquots. Added to 135 
these aliquots were 4 µl of either anti-HSP72:FITC (IgG1) / anti-HSP32:FITC (IgG2B) (Enzo Life 136 
Sciences, USA) or an isotype matched negative control:FITC (AbD Serotec). Following 30 min 137 
incubation in the dark, samples were washed with PBS and then re-suspended in 300 µl PBS ready for 138 
flow cytometry. Samples were analysed by flow cytometry on a BDFACSCalibur® (BD Biosciences, 139 
UK) running CELLQuest Software (BD Biosciences, UK), with monocytes and lymphocytes gated by 140 
forward scatter (FSC; cell size) and side scatter (SSC; cell granularity) properties, with a total of 141 
20,000 events counted. Results were calculated as the ratio of mean fluorescence intensity (MFI) 142 
gained with the anti-HSP antibody to that obtained with the isotype matched negative control. 143 
  144 
Statistical Analysis 145 
All statistical analyses were completed using IBM SPSS Statistics 18 (SPSS Inc. Chicago, IL). Central 146 
tendency and dispersion of the sample data are represented as the mean ± SD. The change in acid-base 147 
variables and biochemical variables across condition and time were analysed using linear mixed 148 
models. The expression of HSP72 and HSP32 were expressed as the ratio of the mean fluorescence 149 
intensity (MFI) gained from the anti-HSP72/anti-HSP32 antibody to that obtained with the isotype 150 
matched negative control. Post hoc tests with Sidak-adjusted p values were used to locate significant 151 
paired differences, with two-tailed statistical significance accepted at p < 0.05. 152 
  153 
Results 154 
The NaHCO3 ingestion protocol significantly elevated blood pH, HCO3- and base excess at rest. EXB1 155 
significantly altered all acid-base variables in PLAC, with pH, HCO3-, and base excess all maintained 156 
closer to pre-exercise values in BICARB (Table 1). 157 
  158 
HSP72 was significantly higher post EXB1 in PLAC compared to BICARB (Fig 2) (33 vs. 8% increase 159 
respectively; F = 4.588, p = 0.050), (Fig 1) a result apparent in all participants (Fig 3). The HSP72 160 
response following EXB2 was similar in both conditions (F = 2.633, p = 0.115), with a significant main 161 
effect for time (F = 13.484, p < 0.001) whereby HSP72 significantly increased 60-min post exercise (p 162 
< 0.001) (Fig 2). HSP32 was unchanged following EXB1 (less than 10% change in both trials), but was 163 
significantly higher (F = 11.085, p < 0.001) 60-min post EXB2 compared to rest and pre EXB2 (p < 164 
0.001) regardless of condition (Fig 4). Furthermore HSP32 was significantly higher immediately post 165 
EXB2 compared with immediately before (p = 0.018) regardless of condition. The concentration of 166 
protein carbonyl did not change significantly from rest throughout the testing period (F = 1.920 p = 167 
0.174), and was comparable between conditions (F = 1.476, p = 0.249) (Table 2). 168 
  169 
 170 
 171 
Discussion 172 
The efficacy of the supplementation protocol was demonstrated by the observation of a significantly 173 
altered blood acid-base balance prior to EXB1 (Table 1), and a significantly attenuated HSP72 174 
response post EXB1 in the BICARB trial as per previous research (Peart et al, 2013a). A lower basal 175 
level of HSP72 prior to EXB2 in BICARB though did not affect the magnitude of the response 176 
following the 90-min protocol of EXB2. Hypoxia is another stimulus that can result in ubiquitin- 177 
proteasome mediated protein degradation, via induction by hypoxia-inducible factor (HIF) (Brahimi-178 
Horn and Pouysségur, 2005). Taylor et al (2012) reported a significantly attenuated HSP72 response 179 
post-exercise (~50%) after basal HSP72 expression was elevated via a hypoxic exposure, therefore it 180 
could have been expected that the trial with the lower basal HSP72 (BICARB) prior to EXB2 would 181 
have resulted in increased HSP72 expression following the bout. However it must be noted that the 182 
average changes in basal levels between experimental conditions in the research from Taylor et al 183 
(2012) was higher than in the present study (67% and 31% respectively). Therefore it may be the case 184 
that the HSP72 response to EXB1 in this study was not of a high enough magnitude to influence the 185 
response to EXB2. 186 
 187 
As other authors have shown that increasing the level of HSP72 prior to exercise can improve defences 188 
to the oxidative damage associated with exercise (Taylor et al., 2012), both HSP32 and protein 189 
carbonyl were measured prior to and after EXB2. Monocyte HSP32 was induced after EXB2 to the 190 
same extent in both conditions. This is in contrast to the HSP32 response to the same 90-min exercise 191 
bout in previous research, which was attenuated under BICARB conditions (Peart et al. 2013b). In the 192 
current study acid-base values had returned to homeostasis prior to EXB2 resulting in comparable acid-193 
base results between conditions (Table 1), whereas in the previous study blood pH, base excess and 194 
HCO3 were significantly different between conditions prior to and throughout the exercise. This 195 
finding supports our previous suggestions that increased oxidative damage is not necessarily the only 196 
stimulus for increased HSP32 and that this particular HSP is highly sensitive to acid-base changes in 197 
vivo (Peart et al. 2013b) as well as in vitro (Christou et al, 2004). 198 
  199 
The protein carbonyl data adds further support for the notion that oxidative stress is not the sole 200 
stimulus for increases in HSP32. Protein carbonyl was measured in this study as a second marker more 201 
specific to protein oxidative damage after HSP32 was significantly attenuated in the previous research 202 
(Peart et al. 2013b). Although quantification of this marker of protein oxidative damage has previously 203 
produced conflicting responses following anaerobic exercise (Alessio et al., 2000, Bloomer et al., 2006, 204 
Bloomer et al., 2007b, Bloomer et al., 2005), it has been widely reported to increase following exercise 205 
typically aerobic in nature. Such exercises include cycling interventions lasting 15 to 120-min 206 
(Alessio et al., 2000, Bloomer et al., 2007a, Michailidis et al., 2007), a half marathon race (Sureda et 207 
al., 2013) and ultra-distance cycling (Tauler et al., 2003) and running (Radak et al., 2000). Despite this 208 
trend seen in previous research, protein carbonyl did not increase at any time point throughout the 209 
testing period in this study nor was any difference observed between conditions. The only other study 210 
reporting no increase in protein carbonyl following aerobic exercise utilised a 90-min cycling protocol 211 
at 70% of maximum (Morillas-Ruiz et al., 2005). Fisher-Wellman and Bloomer (2009) have suggested 212 
that studies reporting null findings for protein carbonyl may be due to insufficient sampling times, 213 
exercise protocols that are too short or physical training status of the participants. Additionally, some 214 
authors have reported peaks in protein carbonyl occurring around 4-6 hours post-exercise (Bloomer et 215 
al., 2005, Michailidis et al., 2007), therefore it is possible that sample timings in this study may have 216 
contributed to no observed increases in protein carbonyl, as the final blood sample was 60-min post 217 
EXB2, and Morillas-Ruiz et al, (2005) only took a sample 20-min post exercise. However, other 218 
authors have demonstrated peaks in protein carbonyl immediately post-exercise of a similar duration to 219 
the current study (Bloomer 2007a, Sureda et al, 2013). Finally the training status is unlikely to have 220 
resulted in the absence of an increased protein carbonyl from rest in this study as the participants were 221 
less physically active compared with other studies, and lesser trained individuals have been shown to 222 
have greater protein carbonyl responses following exercise (Tauler et al., 2003). In the current study 223 
participants cycled predominantly at 40-60% of maximum during EXB2, whereas Bloomer et al, 224 
(2007a) used an intensity of 70% and Michailidis et al, (2007) 70-90% maximum suggesting 225 
the  current protocol may not have been a high enough stimulus to elicit increases in protein carbonyl. 226 
However Morillas-Ruiz et al, (2005) also applied an intensity of 70% with null findings. Furthermore 227 
increases in oxygen consumption are unlikely to be the sole cause of protein carbonyl increases 228 
following exercise as authors have at times demonstrated increases in protein carbonyl following 229 
exercises of relatively low  demands compared to sub-maximal exercise (Alessio et al., 2000, 230 
Bloomer et al., 2005). In summary we witnessed no increase in protein carbonyl concentration 231 
following either exercise bout, which is in contrast to previous work using similar exercise 232 
modalities/duration. The reason for this is unclear as this study also had similar sampling times 233 
following exercise to other studies, a factor which has been suggested to contribute to null findings 234 
(Fisher-Wellman and Bloomer, 2009).  235 
  236 
The increase in HSP72 after EXB1 observed in this study is less than the results reported in previous 237 
research (~30% and ~80% respectively) (Peart et al, 2013a). So as acknowledged earlier in the 238 
discussion, the magnitude of the response may have been inadequate to influence HSP72 expression 239 
following EXB2, and it is unclear whether an increase similar to the original study would have had 240 
more effect upon the subsequent response. This draws attention to whether documenting the stress 241 
response on a single day of training is necessarily fully reflective of the role of HSP72 in sport and 242 
exercise and future investigations should document intra-individual variance in the response to acute 243 
exercise. Other authors have shown that protein damage can progressively increase over several days 244 
training, as can the intracellular HSP72 response to exercise (Whitham et al., 2004). Therefore future 245 
work may also consider further examining the effect of pre-exercise mediated alterations in the 246 
response of HSP72 by documenting the implications of manipulating the HSP72 stress response over a 247 
longer period training, and any subsequent effect upon exercise performance and recovery times. This 248 
would allow further insight into whether chronic attenuation of HSP72 would have additional 249 
implications during a presumably more stressful period, and may inform future work investigating the 250 
hormetic nature of oxidative stress for training adaptation (Powers et al, 2010). From a practical 251 
viewpoint these findings suggest that individuals choosing to ingest NaHCO3 acutely for its possible 252 
ergogenic effect (Peart et al. 2012) do not risk interfering with the physiological stress response to a 253 
subsequent exercise in the same day. 254 
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Fig 1  Schematic of the experimental trials 407 
 408 
Fig 2 Mean ± SD Monocyte expressed HSP72 pre and post EXB1 and EXB2 during the PLAC and 409 
BICARB trials. * significantly different to BICARB (p = 0.05), † significantly different to pre EXB2 410 
(p  <0.001), ‡ significantly different to 0-min post EXB2 (p < 0.001).   411 
 412 
Fig 3 Individual changes in monocyte expressed HSP72 after EXB1, expressed as percentage change 413 
from rest 414 
 415 
Fig 4 Mean ± SD Monocyte expressed HSP32 during the PLAC and BICARB trials. * significantly 416 
different to pre EXB1 and pre EXB2 (p  ≤ 0.041). 417 
  418 
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 420 
 421 
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 425 
 426 
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 428 
 429 
 430 
 431 
 432 
 433 
 434 
 435 
 436 
Table 1 Acid-base characteristics pre- and post-NaHCO3 ingestion, immediately post EXB1 and 
pre EXB2 (means ± SD) 
  
    Pre-ingestion Post-
ingestion 
Post EXB1 Pre EXB2 
pH PLAC 7.40 ± 0.01 7.40 ± 0.02 7.19 ± 0.04† 7.39 ± 0.02 
  BICARB 7.39 ± 0.01 7.44 ± 0.02*‡ 7.27 ± 0.05†‡ 7.40 ± 0.02 
HCO3- (mmol/L) PLAC 24.56 ± 0.70 23.02 ± 3.49 14.85 ± 4.35† 24.22 ± 1.19 
  BICARB 24.28 ± 1.15 27.5 ± 0.97*‡ 15.45 ± 2.21† 25.9 ± 1.53 
Base excess (mEq/L) PLAC 0.35 ± 1.37 0.30 ± 1.00 -13.93 ± 2.05† 0.43 ± 1.21 
  BICARB 0.44 ± 1.21 3.84 ± 1.18*‡ -10.82 ± 3.09†‡ 2.47 ± 1.49‡ 
Lactate (mmol/L) PLAC 1.40 ± 0.47 1.38 ± 0.28 13.65 ± 1.09† 2.16 ± 0.38† 
  BICARB 1.28 ± 1.66 1.65 ± 0.23 14.30 ± 1.89† 2.50 ± 0.48† 
*significantly different to pre-ingestion (p<0.05), †significantly different to post-ingestion (p<0.05), 
‡significantly different to PLAC (p<0.05) 
 437 
Table 2 Protein carbonyl (nmol/ml) during the PLAC and BICARB trials (means ± SD) 
  
    Pre EXB1 90-min post 
EXB1 / Pre 
EXB2 
0-min post 
EXB2 
60-min post 
EXB2 
Protein carbonyl  PLAC 44.18 ± 8.07 42.23 ± 5.02 40.55 ± 5.55 36.73 ± 11.45 
  BICARB 48.69 ± 12.27 49.18 ± 8.32 38.16 ± 12.04 46.05 ± 13.54 
 438 
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